ABL

Abbott Laboratories · HAN:ABL

94.62 EUR−0.5200 −0.55%

Abbott Laboratories (HAN:ABL) last traded at 94.62 EUR, down 0.55% on the day. Over the past year the stock is down 11.67%. Its 52-week range is 70.02 to 112.76. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open94.82

Day range94.62 – 94.82

52-week range70.02 – 112.76

Volume0

Average volume (10 days)0

Market cap (USD)183.77 B

P/E39.57

EPS (TTM) (USD)2.71

Dividend yield2.37%

Beta (1 year)0.3618

Revenue (TTM) (USD)48.23 B

Employees115.00 K

Performance

+2.47%1 week

+10.54%1 month

+1.83%3 months

+27.35%6 months

−11.04%Year to date

−11.67%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.